Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred ...

The management of carotid-artery stenosis that has not caused recent symptoms — asymptomatic carotid stenosis — has been controversial. Clinical trials that began more than 30 years ago showed a small ...

This feature about a man hospitalized for uncomplicated diverticulitis who is found to have high blood pressure offers a case vignette accompanied by two essays, one supporting watchful waiting and ...

A 26-year-old woman was referred to the pulmonary hypertension clinic with a 6-month history of exertional dyspnea and hoarseness. Vocal-fold paralysis was seen on laryngoscopy (shown in a video).

The U.S. antitrust paradigm can’t fully counteract the risks posed by health care corporatization. Regulators need robust procompetitive strategies to recenter patients and health as measures of ...

The U.S. government has terminated grants funding work it considers to address “DEI,” conflating health equity research with efforts to change the composition and climate of the scientific workforce.

The painkilling, antipyretic, and antiinflammatory properties of aspirin have been known for centuries. The understanding that aspirin targets cyclooxygenase-1 (COX-1) (also known as ...

After 60 years of cogitation about normal-pressure hydrocephalus, the results of a worthy randomized trial that assessed the effects of cerebrospinal fluid (CSF) shunting are now published in the ...

To the Editor: Kawai et al. (May 15 issue)1 report a gene-edited porcine kidney xenograft in a human participant who survived for 52 days, an outcome that represents a landmark achievement in the f ...

For decades, the guidance was simple: treat a provoked venous thromboembolism (VTE) — one caused by a transient factor such as surgery, trauma, or immobility — for 3 to 6 months, stop, and move on. 1 ...

Corporatization represents a deal between medical organizations and investors and presumably benefits those entities. But the key question for society is whether it benefits patients and payers.